Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors.
Anja MeyerPaula S WittekindKonstantin KotschenreutherJoanna SchillerJulia von TresckowThomas H HaakDavid M KoflerPublished in: Annals of the rheumatic diseases (2019)